期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Research on the Mechanism of Compound Lizard Powder Gel in Treating Ulcerative Colitis Based on 16SrDNA
1
作者 HANJinrong MAXiulan +1 位作者 WANGJialin ZHUXijie 《外文科技期刊数据库(文摘版)医药卫生》 2022年第7期109-113,共5页
Objective: the purpose of this experiment is to study the effect of compound lizard powder gel on intestinal flora of rats with ulcerative colitis (UC). Methods: SPF male SD rats were randomly divided into 6 groups: b... Objective: the purpose of this experiment is to study the effect of compound lizard powder gel on intestinal flora of rats with ulcerative colitis (UC). Methods: SPF male SD rats were randomly divided into 6 groups: blank group, model control group, compound lizard powder gel high, middle and low groups and sulfasalazine tablet treatment group. The clinical behavior of rats was observed daily during the modeling of TNBS, modeling period and drug intervention treatment period, and 16S rDNA high-throughput sequencing technique was used to compare and analyze the flora structure and bacteria genus differences in fresh feces of six groups of rats. Results: clinical behavior observation showed that the clinical condition of rats in the blank group was always good. In the model group, some rats had soft stools on the first day of modeling, and their spirit, activity and hair gradually changed. By the third day, the symptoms of loose stools and bloody stools gradually worsened. After treatment, the clinical symptoms of each group changed, but each group had its own characteristics. The sequencing results show that the current sequencing depth can fully reflect the diversity of microorganisms contained in the sample;PCoA analysis showed that the percentages of PCA1 and PCA2 in the score chart explaining population variance were 46.92% and 10.05% respectively. Multi-dimensional analysis shows that compared with the model control group and the blank group, the difference of flora composition between compound lizard powder group and sulfasalazine tablet treatment group is smaller. Analysis of the community structure of intestinal contents showed that the highest abundance in each group of samples at phylum level were phylum sclerenchyma and phycobacterium. After 14 days of drug intervention, the abundance of sclerenchyma and Bacteroides in compound lizard powder group and sulfasalazine tablet treatment group increased, and the abundance of Proteobacteria decreased, especially in compound Lizard powder middle dose group. In the control group, the abundance of degenerated phylum increased significantly. Genus levels, the highest abundance in each group of samples were Muribaculaceae_ unclassified and Lactobacillus. After 14 days of drug intervention, the abundance of Ruminococcaceae_UCG?005 in compound lizard powder group and sulfasalazine tablet treatment group increased significantly, and the abundance of Bacteroides in model control group was significantly higher than that in blank control group and compound lizard powder treatment groups. The lactic acid bacteria in the middle dosage group of compound lizard powder were higher than those in the high and low dosage groups of compound lizard powder and sulfasalazine tablets group. Conclusion: compound lizard powder gel, especially in the middle dosage group, is more effective in adjusting the intestinal flora structure and bacteria genus difference of UC. 展开更多
关键词 16SrDNA high-throughput sequencing intestinal microecology ulcerative colitis compound lizard powder gel
在线阅读 下载PDF
复方蜥蜴散凝胶对溃疡性结肠炎模型大鼠Claudin-1和Zonulin蛋白表达的影响 被引量:3
2
作者 马秀兰 王佳林 朱西杰 《辽宁中医杂志》 CAS 2022年第12期198-201,I0020,I0021,共6页
目的 研究复方蜥蜴散凝胶对溃疡性结肠炎(UC)大鼠结肠组织Claudin-1和Zonulin蛋白的表达影响,探究其治疗UC的机制。方法 选取SD雄性大鼠120只,随机分为空白对照组和模型组,模型组以2,4,6-三硝基苯磺酸(TNBS)造模,造模成功后,随机分为复... 目的 研究复方蜥蜴散凝胶对溃疡性结肠炎(UC)大鼠结肠组织Claudin-1和Zonulin蛋白的表达影响,探究其治疗UC的机制。方法 选取SD雄性大鼠120只,随机分为空白对照组和模型组,模型组以2,4,6-三硝基苯磺酸(TNBS)造模,造模成功后,随机分为复方蜥蜴散凝胶低、中、高剂量组,柳氮磺吡啶组,模型对照组。给予复方蜥蜴散凝胶不同浓度、柳氮磺吡啶、生理盐水,治疗14 d,观察大鼠一般情况;干预后麻醉处死,取病变结肠组织,观察结肠形态学变化,Western blot法和免疫组化法(IHC)检测大鼠结肠组织中Claudin-1、Zonulin蛋白的表达,统计分析实验结果。结果 模型对照组与空白对照组比较:大鼠结肠上皮细胞受损严重、腺体破坏、出现溃疡等病变,并伴有大量炎性细胞浸润。复方蜥蜴散凝胶高、中、低剂量组及柳氮磺吡啶组较模型组:大鼠肠上皮细胞损伤程度减轻,溃疡灶数减少,溃疡面积缩小,炎性细胞浸润减少。模型对照组与空白对照组比较,大鼠结肠组织中Claudin-1蛋白表达水平降低(P<0.05),Zonulin蛋白表达水平升高(P<0.05);柳氮磺吡啶组及各治疗组与模型对照组比较,Claudin-1蛋白表达水平明显升高(P<0.05),Zonulin蛋白表达水平明显降低(P<0.05)。结论 复方蜥蜴散凝胶可以通过影响蛋白表达水平,修复损伤结肠黏膜,发挥治疗UC的作用。 展开更多
关键词 溃疡性结肠炎 复方蜥蜴散凝胶 CLAUDIN-1 ZONULIN SD大鼠
原文传递
复方蜥蜴散凝胶对溃疡性结肠炎模型大鼠Cingulin、Occludin、ZO-1蛋白的表达影响 被引量:6
3
作者 马秀兰 王佳林 +1 位作者 张兴艳 朱西杰 《实用中医内科杂志》 2022年第8期7-10,I0004,I0005,共6页
目的研究复方蜥蜴散凝胶对溃疡性结肠炎(UC)大鼠结肠组织Cingulin、Occludin、ZO-1蛋白的表达影响,探究其治疗UC的机制及疗效。方法选取SD雄性大鼠120只,随机分为空白对照组和模型组。模型组以2,4,6-三硝基苯磺酸(TNBS)造模,造模成功后... 目的研究复方蜥蜴散凝胶对溃疡性结肠炎(UC)大鼠结肠组织Cingulin、Occludin、ZO-1蛋白的表达影响,探究其治疗UC的机制及疗效。方法选取SD雄性大鼠120只,随机分为空白对照组和模型组。模型组以2,4,6-三硝基苯磺酸(TNBS)造模,造模成功后,随机分为复方蜥蜴散凝胶低、中、高剂量组,柳氮磺吡啶组,模型对照组。分别用复方蜥蜴散凝胶不同浓度、柳氮磺吡啶、氯化钠溶液,灌胃及中药喂养方式治疗14 d,观察大鼠一般情况;干预治疗后处死动物,取病变结肠组织,western blot法和免疫组化法(IHC)检测大鼠结肠组织中Cingulin、Occludin、ZO-1蛋白的表达,并对实验结果进行统计分析。结果模型组与空白组比较:大鼠体质量明显减轻、毛色晦暗无泽、食量减少、喜扎堆。病变结肠组织中Cingulin、Occludin、ZO-1表达明显降低。各治疗组与模型组比较:复方蜥蜴散凝胶高、中、低剂量组及柳氮磺吡啶组较模型组体质量上涨、饮水及食量增加、较活跃、毛色光泽。通过western blot法和免疫组化法对大鼠结肠组织Cingulin、Occludin、ZO-1的蛋白表达分析:模型对照组与空白对照组比较,大鼠结肠组织中Cingulin、Occludin、ZO-1蛋白表达水平均降低(P<0.05);柳氮磺吡啶组及复方蜥蜴散凝胶各治疗组与模型组比较,Cingulin、Occludin、ZO-1蛋白表达水平均明显升高(P<0.05)。尤其以复方蜥蜴散凝胶高剂量组显著明显(P<0.01),说明复方蜥蜴散凝胶高剂量组溃疡性结肠炎黏膜的修复作用最强。结论复方蜥蜴散凝胶可修复损伤结肠黏膜,治疗UC疗效可观。 展开更多
关键词 溃疡性结肠炎 复方蜥蜴散凝胶 CINGULIN OCCLUDIN ZO-1 SD大鼠
原文传递
复方蜥蜴散凝胶调节PLGC大鼠肠道菌群治疗胃癌前病变的作用机制 被引量:4
4
作者 王佳林 朱西杰 +1 位作者 马秀兰 王艺臻 《中国老年学杂志》 CAS 北大核心 2023年第13期3192-3197,共6页
目的研究复方蜥蜴散凝胶通过调节胃癌前病变(PLGC)模型大鼠肠道内益生菌与致病菌平衡,修复损伤胃黏膜,抑制PLGC进展。方法将120只SD雄性大鼠随机分成空白对照组20只,模型组100只,采用甲基硝基亚硝基胍(MNNG)复合造模法制备模型。大鼠胃... 目的研究复方蜥蜴散凝胶通过调节胃癌前病变(PLGC)模型大鼠肠道内益生菌与致病菌平衡,修复损伤胃黏膜,抑制PLGC进展。方法将120只SD雄性大鼠随机分成空白对照组20只,模型组100只,采用甲基硝基亚硝基胍(MNNG)复合造模法制备模型。大鼠胃组织取材后,采用苏木素-伊红(HE)病理检测分析黏膜组织情况,对收集的粪便样本进行16S rRNA基因测序分析,采用R语言对菌群与通路进行关联性分析。结果复方蜥蜴散凝胶治疗后发现7个菌属发生了明显变化,分别是阿克曼菌属、类杆菌属、粪球菌属、乳杆菌属、普雷沃菌属、瘤胃球菌属、苏黎世杆菌属。结论复方蜥蜴散凝胶可通过对肠道菌群的双向调节作用如增殖有益菌,抑制有害菌,平衡肠道菌群结构,治疗PLGC。 展开更多
关键词 复方蜥蜴散凝胶 胃癌前病变(PLGC) 肠道菌群 16 S rRNA
暂未订购
基于PI3K/AKT/mTOR信号通路研究复方蜥蜴散凝胶对胃癌前病变模型大鼠的调控作用 被引量:7
5
作者 王艺臻 王佳林 朱西杰 《中医学报》 CAS 2021年第10期2154-2158,共5页
目的:基于PI3K/Akt/mTOR信号通路研究复方蜥蜴散凝胶对单功能烷化剂甲基硝基亚硝基胍(N-methyl-N'-nitro-N-nitrosoguanidine,MNNG)诱导的胃癌前病变模型大鼠的调控作用。方法:采用MNNG溶液配合饥饱失常及情绪刺激等综合因素制备胃... 目的:基于PI3K/Akt/mTOR信号通路研究复方蜥蜴散凝胶对单功能烷化剂甲基硝基亚硝基胍(N-methyl-N'-nitro-N-nitrosoguanidine,MNNG)诱导的胃癌前病变模型大鼠的调控作用。方法:采用MNNG溶液配合饥饱失常及情绪刺激等综合因素制备胃癌前病变模型。造模成功后将其随机分为模型组、维酶素组(7 g·kg^(-1))及复方蜥蜴散凝胶高、中、低剂量组(28 g·kg^(-1)、14 g·kg^(-1)、7 g·kg^(-1)),另设空白组,连续给予相应的药物12周。HE染色观察大鼠胃组织病理变化;Western Blot检测大鼠胃组织PI3K、AKT、mTOR蛋白表达。结果:与模型组比较,复方蜥蜴散凝胶高、中、低剂量组及维酶素组大鼠胃组织PI3K、AKT、mTOR蛋白表达显著下调(P<0.05);胃组织病理损伤有所改善。结论:复方蜥蜴散凝胶治疗胃癌前病变疗效确切,可能与PI3K/AKT/mTOR信号通路有关。 展开更多
关键词 复方蜥蜴散凝胶 胃癌前病变 PI3K/AKT/mTOR信号通路 大鼠
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部